Found 549739 clinical trials
Sort by:
Early Treatment ctDNA Dynamics to Predict Response to Chemotherapy
Active, not recruiting
- Conditions
- Metastatic Pancreatic Cancer
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Northwell Health
- Target Recruit Count
- 24
- Registration Number
- NCT07122466
- Locations
- 🇺🇸
Zuckerberg Cancer Center, New Hyde Park, New York, United States
Real World Effectiveness of Bictegravir/Emtricitabine/Tenofovir Alafenamide(BIC/FTC/TAF) in PLWH in Precarity Settings in France -IMEA073
Not yet recruiting
- Conditions
- HIV-1BIC/FTC/TAFPublic Universal Healthcare Insurance CoverageLow Income Population
- Interventions
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Institut de Médecine et d'Epidémiologie Appliquée - Fondation Internationale Léon M'Ba
- Target Recruit Count
- 320
- Registration Number
- NCT07122557
Prognostic Factors for Fatigue in Patients With Systemic Lupus Erythematosus
Not yet recruiting
- Conditions
- Lupus Erythematosus, Systemic
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Investigación en Hemofilia y Fisioterapia
- Target Recruit Count
- 88
- Registration Number
- NCT07123220
- Locations
- 🇪🇸
Universidad de Oviedo, Almería, Andalucia, Spain
Effect of Caloric Content and Timing of Meal on Postprandial Substrate Oxidation and Pulse Wave Analysis
Not Applicable
Recruiting
- Conditions
- FeedingMetabolismIndirect CalorimetryPulse Wave AnalysisPulse Wave VelocityCarbohydrate MetabolismBlood Flow VelocityFatty Acid MetabolismHealthy Participants
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- George Washington University
- Target Recruit Count
- 20
- Registration Number
- NCT07122765
- Locations
- 🇺🇸
George Washington University School of Public Health, Washington, District of Columbia, United States
Pharmacokinetics, Pharmacodynamics Profile and Tolerance of HRS-9231 in Healthy Subjects
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Shanghai Shengdi Pharmaceutical Co., Ltd
- Target Recruit Count
- 40
- Registration Number
- NCT07123376
- Locations
- 🇨🇳
The First Affiliated Hospital of Soochow University, Suzhou, Jiangsu, China
18F-Pentixafor PET in Hematologic Malignancies
Recruiting
- Conditions
- Hematological Malignancies
- Interventions
- Drug: 18F-Pentixafor
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- First Affiliated Hospital of Zhejiang University
- Target Recruit Count
- 100
- Registration Number
- NCT07122674
- Locations
- 🇨🇳
The First Affiliated Hospital of Zhejiang University School of Medicine, Hangzhou, Zhejiang, China
2D-shear Wave Spleen Elastography in Clinically Significant Portal Hypertension and High-risk Varices
Not yet recruiting
- Conditions
- Portal Hypertension Related to CirrhosisEsophageal Varices
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Target Recruit Count
- 450
- Registration Number
- NCT07122622
Phase 2 Trial to Evaluate the Efficacy, Safety of Allogeneic Mitochondria (PN-101) in Patients With Refractory Polymyositis or Dermatomyositis
Not Applicable
Not yet recruiting
- Conditions
- PolymyositisDermatomyositis
- Interventions
- Biological: placebo
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Paean Biotechnology Inc.
- Target Recruit Count
- 36
- Registration Number
- NCT07122648
- Locations
- 🇰🇷
Chung-Ang University Gwang Myeong Hospital, Gwangmyeong, Gyeonggi-do, Korea, Republic of
🇰🇷Kyung Hee University Medical Center, Seoul, Korea, Republic of
🇰🇷Seoul National University, Seoul, Korea, Republic of
Enhancing Uptake of Needle and Syringe Programs in Canadian Federal Prisons
Not Applicable
Recruiting
- Conditions
- HIVHepatitis C Virus (HCV)
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- McGill University Health Centre/Research Institute of the McGill University Health Centre
- Target Recruit Count
- 548
- Registration Number
- NCT07122219
- Locations
- 🇨🇦
Edmonton Institution for Women, Edmonton, Alberta, Canada
🇨🇦Fraser Valley Institution for Women, Abbotsford, British Columbia, Canada
🇨🇦Mission Institution, Mission, British Columbia, Canada
Post-Approval Study of PALMAZ MULLINS XD™ in Treating Pulmonary Artery Stenosis
Not yet recruiting
- Conditions
- Pulmonary Artery Stenosis
- First Posted Date
- 2025-08-14
- Last Posted Date
- 2025-08-14
- Lead Sponsor
- Cordis Corporation
- Target Recruit Count
- 75
- Registration Number
- NCT07122518